Abstract:Previous studies have established the presence of high numbers of activated T lymphocytes and "aberrant" expression of major histocompatibility complex class II antigens by endothelial and smooth muscle cells in human atherosclerotic lesions, implicating the involvement of a local cellular immune response. The identity of the antigen(s) eliciting this immune response, the extent of their effect, and the atherogenic stage at which they occur remain to be determined. In the present studies, 120 normocholesterolemic New Zealand White rabbits were immunized one or more times with various antigens, with or without adjuvants. The antigens and adjuvants included human or rabbit atherosclerotic lesion proteins, ovalbumin, Freund's complete and/or incomplete adjuvants, recombinant mycobacterial heat shock protein 65 (hsp65), and two hsp-free adjuvants, Ribi complete adjuvant and lipopeptide. In addition, some groups received a high-cholesterol diet. Sixteen weeks after the first immunization the animals were killed, and arteriosclerotic lesions in the intima of the aortic arch were found to have developed only in those animals immunized with antigenic preparations containing hsp, either in the form of whole mycobacteria or as purified recombinant hsp65, although their serum cholesterol levels were normal. No arteriosclerotic changes exceeding those of controls were found in the other groups, irrespective of the antigen used. Immunohistopathologic examination revealed that the lesions contained 20% T cells, 10-30% macrophages, and 10-40% smooth muscle cells. Analysis of the peripheral blood T-lymphocyte proliferative responses revealed that the occurrence of lesions was positively correlated with the presence of hsp65-reactive T cells, suggesting that hsp65 is involved in the induction of arteriosclerotic lesions. Furthermore, combined immunization with hsp-containing material and a cholesterol-rich diet provoked development of significantly more severe atherosclerosis and the appearance of characteristic foam cells. We conclude that an (auto)immune response to hsp may initiate the development of atherosclerosis and that a high blood cholesterol level is only one albeit a very important risk factor.

Immunology Effects of Anti-atherosclerosis Protein Vaccines Based on Heat Shock Protein 65

The Effect of HSP65 and Its Two Functional Peptides in Adjusting Atherosclerosis

The Immunological Effect of Antiatherosclerosis Vaccine

Nasal immunization with different forms of heat shock protein-65 reduced high-cholesterol-diet-driven rabbit atherosclerosis

Effects of Nasal Immunization of Multi-Target Preventive Vaccines on Atherosclerosis

Study on the Preparation and Immunological Effect of an Anti-Atherosclerosis Vaccine

Nasal Immunization with Heat Shock Protein 65 Attenuates Atherosclerosis and Reduces Serum Lipids in Cholesterol-Fed Wild-Type Rabbits Probably Through Different Mechanisms.

Vaccinating Rabbits with a Cholesteryl Ester Transfer Protein (CETP) B-Cell Epitope Carried by Heat Shock Protein-65 (HSP65) for Inducing Anti-Cetp Antibodies and Reducing Aortic Lesions in Vivo.

Induction of Arteriosclerosis in Normocholesterolemic Rabbits by Immunization with Heat Shock Protein 65.

Promotion of Atherosclerosis in High Cholesterol Diet-Fed Rabbits by Immunization with the P277 Peptide.

In silico analyses of heat shock protein 60 and calreticulin to designing a novel vaccine shifting immune response toward T helper 2 in atherosclerosis

Vaccination with A Dna Vaccine Based on Human Psca and Hsp70 Adjuvant Enhances the Antigen-Specific Cd8(+) T-Cell Response and Inhibits the Psca(+) Tumors Growth in Mice

Inhibition of Arteriosclerosis by T-Cell Depletion in Normocholesterolemic Rabbits Immunized with Heat Shock Protein 65

Construction, Expression, Purification and Immunology Effect of an Antiatherosclerosis Chimeric Enzyme Vaccine in Escherichia Coli

A Novel Atherogenic Epitope from Mycobacterium Tuberculosis Heat Shock Protein 65 Enhances Atherosclerosis in Rabbit and Ldl Receptor-Deficient Mice

Increased Expression of Heat-Shock Protein-65 Coincides with A Population of Infiltrating T-Lymphocytes in Atherosclerotic Lesions of Rabbits Specifically Responding to Heat-Shock Protein-65

Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.

A Th2 immune shift to heat shock protein 65 fails to arrest atherosclerosis: Proatherogenic role of Th2-deviated autoantibodies.

Effect of an Antidiabetic Vaccine IA-2-P2 on Atherosclerosis

Heat shock protein 65 promotes atherosclerosis through impairing the properties of high density lipoprotein.

Effect of Subcutaneous Immunization with HSP65 on Cholesterol Efflux from Macrophagocytes in Mice and Its Mechanism